AbbVie Director Jennifer L. Davis to Resign From Board
Jennifer L. Davis will leave AbbVie’s board effective November 2, 2026, following her appointment as Align Technology CEO.
Jennifer L. Davis will leave AbbVie’s board effective November 2, 2026, following her appointment as Align Technology CEO.